These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3079802

  • 21. Influence of a transfusion of donor leukocytes treated with 8-methoxypsoralen and long-wave ultraviolet light (PUVA) on skin allograft survival in mice.
    Gruner S, Noack F, Meffert H.
    Biomed Biochim Acta; 1989; 48(7):477-85. PubMed ID: 2803285
    [Abstract] [Full Text] [Related]

  • 22. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
    Zhong T, Liu Y, Jiang J, Wang H, Temple CL, Sun H, Garcia B, Zhong R, Ross DC.
    Transplantation; 2007 Dec 27; 84(12):1636-43. PubMed ID: 18165776
    [Abstract] [Full Text] [Related]

  • 23. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD, Qin L, Lin J, Yagita H, Bromberg JS.
    J Immunol; 1993 Dec 15; 151(12):7249-59. PubMed ID: 7903105
    [Abstract] [Full Text] [Related]

  • 24. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J, Zhu SN, Streilein JW, Dana MR.
    Invest Ophthalmol Vis Sci; 2000 Dec 15; 41(13):4203-8. PubMed ID: 11095616
    [Abstract] [Full Text] [Related]

  • 25. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor.
    Liang S, Baibakov B, Horuzsko A.
    Eur J Immunol; 2002 Sep 15; 32(9):2418-26. PubMed ID: 12207326
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Further characterization of Thy 1+ donor cells that promote allograft tolerance by F-1 spleen cells in sublethally-irradiated parental hosts across a complete MHC disparity.
    Pierce GE, Steers JL.
    Transplant Proc; 1991 Feb 15; 23(1 Pt 1):149-51. PubMed ID: 1671300
    [No Abstract] [Full Text] [Related]

  • 32. The dominant role of Ia antibodies in the passive enhancement of H-2 incompatible skin grafts.
    Staines NA, Guy K, Davies DA.
    Eur J Immunol; 1975 Nov 15; 5(11):782-9. PubMed ID: 802473
    [Abstract] [Full Text] [Related]

  • 33. The effect of anti-interleukin-2 receptor monoclonal antibody on allograft rejection.
    Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Koltun WA, Schoen FJ, Ythier A, Strom TB.
    Transplantation; 1985 Dec 15; 40(6):719-22. PubMed ID: 3934807
    [Abstract] [Full Text] [Related]

  • 34. Prolonged minor allograft survival in intravenously primed mice. Effect of recipient's age and of prior immunity to minor H antigens on the priming cells.
    Johnson LL.
    Transplantation; 1989 Jun 15; 47(6):1017-20. PubMed ID: 2660339
    [Abstract] [Full Text] [Related]

  • 35. [Immunological analysis of allogenic skin grafts: prolongation of the survival of skin grafts in mice].
    Ishii N, Nakajima H, Nagai R.
    Nihon Hifuka Gakkai Zasshi; 1988 Apr 15; 98(4):403-7. PubMed ID: 3068381
    [No Abstract] [Full Text] [Related]

  • 36. Characteristics of histocompatibility barriers in congenic strains of mice. III. Passive enhancement of skin allografts in X-irradiated hosts.
    Cantrell JL, Kaliss N, Hildemann WH.
    Transplantation; 1975 Feb 15; 19(2):95-101. PubMed ID: 1091043
    [Abstract] [Full Text] [Related]

  • 37. [Extension of graft survival time by means of a modification of the treatment with autologous blood].
    Seifert J.
    Fortschr Med; 1979 Sep 27; 97(36):1576-80. PubMed ID: 387558
    [Abstract] [Full Text] [Related]

  • 38. Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.
    Kirkman RL, Barrett LV, Gaulton GN, Kelley VE, Ythier A, Strom TB.
    J Exp Med; 1985 Jul 01; 162(1):358-62. PubMed ID: 3925068
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.